Continuation of research and development activities
First written in FY2016-Q2. . Latest entry: FY2026-H1.
45 other companies' latest entry also says "Other".
- FY2026-H1Mid-year update to R&D expenditure resultsAnnual report
「The total research and development expenses for the current interim consolidated accounting period were ¥1,239 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the current interim consolidated accounting period totaled ¥1,239 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2025-H1Mid-year update to R&D expenditure resultsAnnual report
「The total research and development expenses for the current interim consolidated accounting period were ¥856 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the current interim consolidated accounting period totaled ¥856 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2024Annual update to R&D expenditure and resultsAnnual report
「The total research and development expenses for the current consolidated fiscal year were ¥1,619 million.」
Full-year research and development expenses totaled ¥1,619 million. The company described efforts to expand development and strengthen sales of A-XPF, GREEN TAP, AD-2D Gtag, AE-CPR2-H, AE-CPR4-H, AE-VMS Gtag, 6CxOSG and other products. - FY2024-Q2Second-quarter update of research and development expense results for the 112th fiscal yearAnnual report
「The total research and development expenses for the second quarter of the current consolidated cumulative period were ¥803 million.」
Research and development expenses for the second quarter of the 112th fiscal year totaled ¥803 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2024-Q1First-quarter update of research and development expense results for the 112th fiscal yearAnnual report
「The total research and development expenses for the first quarter of the current consolidated cumulative period were ¥363 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the first quarter of the 112th fiscal year totaled ¥363 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2023Annual update to R&D expenditure and resultsAnnual report
「The total research and development expenses for the current consolidated fiscal year were ¥1,415 million.」
Full-year research and development expenses totaled ¥1,415 million. The results described include expanding the A-XPF range, developing and commercializing AE-CRE-H and AE-HFE-H, expanding the scope of VI coating mass production, and rolling out the 6CxOSG series. - FY2023-Q3Third-quarter update of research and development expense results for the 111th fiscal yearAnnual report
「The total research and development expenses for the third quarter of the current consolidated cumulative period were ¥1,018 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the third quarter of the 111th fiscal year totaled ¥1,018 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2023-Q2Second-quarter update of research and development expense results for the 111th fiscal yearAnnual report
「The total research and development expenses for the second quarter of the current consolidated cumulative period were ¥652 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the second quarter of the 111th fiscal year totaled ¥652 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2023-Q1First-quarter update of research and development expense results for the 111th fiscal yearAnnual report
「The total research and development expenses for the first quarter of the current consolidated cumulative period were ¥330 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the first quarter of the 111th fiscal year totaled ¥330 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2022Annual update to R&D expenditure and resultsAnnual report
「The total research and development expenses for the current consolidated fiscal year were ¥1,346 million.」
The company disclosed full-year research and development expenses of ¥1,346 million and described the development and commercialization results for A-XPF, AE-MSS, AE-MS, AE-ML-H, 6CxOSG and other products. - FY2022-Q3Third-quarter update to R&D expenditure resultsAnnual report
「The total research and development expenses for the third quarter of the current consolidated cumulative period were ¥1,012 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the third quarter of the 110th fiscal year totaled ¥1,012 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2022-Q2Second-quarter update to R&D expenditure resultsAnnual report
「The total research and development expenses for the second quarter of the current consolidated cumulative period were ¥692 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the second quarter of the 110th fiscal year totaled ¥692 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2022-Q1First-quarter update to R&D expenditure resultsAnnual report
「The total research and development expenses for the first quarter of the current consolidated cumulative period were ¥340 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the first quarter of the 110th fiscal year totaled ¥340 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2021Annual update to R&D expenditure and resultsAnnual report
「The total research and development expenses for the current consolidated fiscal year were ¥1,374 million.」
The company disclosed full-year research and development expenses of ¥1,374 million and described the results of developing environmentally conscious products, AT-2 R-SPEC, AE-VTS and other products, and EXZ-SFT. - FY2021-Q2Second-quarter update to R&D expenditure resultsAnnual report
「The total research and development expenses for the second quarter of the current consolidated cumulative period were ¥678 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the second quarter of the 109th fiscal year totaled ¥678 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2021-Q1First-quarter update to R&D expenditure resultsAnnual report
「The total research and development expenses for the first quarter of the current consolidated cumulative period were ¥337 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the first quarter of the 109th fiscal year totaled ¥337 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2020-Q3Third-quarter update to R&D expenditure resultsAnnual report
「The total research and development expenses for the third quarter of the current consolidated cumulative period were ¥1,047 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the third quarter were updated to ¥1,047 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2020-Q2Second-quarter update to R&D expenditure resultsAnnual report
「The total research and development expenses for the second quarter of the current consolidated cumulative period were ¥686 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the second quarter were updated to ¥686 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2020-Q1First-quarter update to R&D expenditure resultsAnnual report
「The total research and development expenses for the first quarter of the current consolidated cumulative period were ¥348 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the first quarter totaled ¥348 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2019-Q3Third-quarter update to R&D expenditure resultsAnnual report
「The total research and development expenses for the third quarter of the current consolidated cumulative period were ¥1,186 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the third quarter totaled ¥1,186 million, and the company stated that there were no material changes in its research and development activities. - FY2019-Q2Second-quarter update to R&D expenditure resultsAnnual report
「The total research and development expenses for the second quarter of the current consolidated cumulative period were ¥790 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the second quarter totaled ¥790 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2019-Q1First-quarter update to R&D expenditure resultsAnnual report
「The total research and development expenses for the first quarter of the current consolidated cumulative period were ¥372 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses for the first quarter totaled ¥372 million, and the company stated that there were no material changes in its research and development activities. - FY2018Annual update to R&D expenditure and activity resultsAnnual report
「Total R&D expenditure for the current consolidated fiscal year was ¥1,610 million.」
R&D expenditure for the full year was ¥1,610 million, and the development results, including AT-1, EgiAs coated carbide drills, tools for additive manufacturing and products based on AE-VMS, are described. - FY2018-Q3Third-quarter update to R&D expenditure resultsAnnual report
「Total R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥1,147 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenditure for the cumulative third quarter was ¥1,147 million, and it is stated that there were no material changes in the status of R&D activities. - FY2018-Q2Second-quarter update to R&D expenditure resultsAnnual report
「Total R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥781 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenditure for the cumulative second quarter was ¥781 million, and it is stated that there were no material changes in the status of R&D activities. - FY2018-Q1First-quarter update to R&D expenditure resultsAnnual report
「Total R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥363 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenditure for the first quarter was ¥363 million, and it is stated that there were no material changes in the status of R&D activities. - FY2017Annual update to R&D expenditure and activity resultsAnnual report
「Total R&D expenditure for the current consolidated fiscal year was ¥1,655 million.」
R&D expenditure was ¥1,655 million, and the development results, including the A-TAP and ADF series, the AE-VMS series and surface modification technologies, are described. - FY2017-Q3Update to R&D expenditure resultsAnnual report
「Total R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥1,217 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenditure was updated to ¥1,217 million for the cumulative third quarter, and it is stated that there were no material changes in the status of R&D activities. - FY2017-Q2Update to R&D expenditure resultsAnnual report
「Total R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥811 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenditure was updated to ¥811 million for the cumulative second quarter, and it is stated that there were no material changes in the status of R&D activities. - FY2017-Q1Update to R&D expenditure resultsAnnual report
「Total R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥370 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenditure was updated to ¥370 million for the cumulative first quarter, and it is stated that there were no material changes in the status of R&D activities. - FY2016Annual update to R&D expenditure and resultsAnnual report
「Total R&D expenditure for the current consolidated fiscal year was ¥1,606 million.」
R&D expenditure was updated to ¥1,606 million, and the development results, including the A-brand carbide drills, tools for machining titanium alloys, new rolling machines and new coating films, are also described. - FY2016-Q3Update to R&D expenditure resultsAnnual report
「Total R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥1,202 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenditure was updated to ¥1,202 million, and it is stated that there were no material changes in the status of R&D activities. - FY2016-Q2First statedAnnual report
「Total R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥800 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenditure of ¥800 million was recorded, and it is stated that there were no material changes in the status of R&D activities.